This week’s topics include the safety and efficacy of sitagliptin for type 2 diabetes, use of glucocorticoids and the risk of VTE, and forced smoking abstinence.
Presenting at HRS — Benefits Before the Session, During, and Afterwards
This is why we hold conferences — to share in the value of research and to promote enthusiasm to continue with new endeavors.
Selections from Richard Lehman’s Literature Review: May 13th
This week’s topics include the ADVANCE III trial, the latest fish-oil supplement study, and a review of management strategies for asymptomatic carotid stenosis.
Things I found at HRS 2013: Education, Science, Friends, and Mentors
Looking back at the knowledge gained and friendships kindled at HRS 2013, this Fellow looks forward to HRS 2014.
Blogging at HRS 2013: From The FIT Lounge, Insights From Douglas Zipes About Publishing
I finally managed to walk to the Fellows in Training lounge, hoping to connect with some co-fellows. I did find lot of fellows, but to my surprise Dr. Zipes was there and ready to answer burning questions about getting published.
How Should Recent Trials Affect CRT Practice?
In recent weeks the cardiac resynchronization therapy (CRT) field has been absorbing the publication of the BLOCK HF trial in the New England Journal of Medicine and the publication of the NARROW-CRT trial in Circulation: Arrhythmia and Electrophysiology. These trials raised the possibility that CRT may improve clinical status in some patients with ischemic cardiomyopathy…
Blogging at HRS 2013: Great Takeaways on Day 2
HRS yields useful insights, both personal and professional.
Blogging from HRS 2013: Excitement at the Convention Center and Outside
An emotion-raising debate, a late-breaker session, and technological innovations focus this fellow, despite Denver’s many attractions.
Blogging from HRS 2013: VT/VF Summit, and Bill Clinton Too!
A fellow experiences one exceptional presentation after another at the first day of HRS 2013.
Journal X: Not so Subtle Marketing Messages
My 3-year-old daughter helps me see the influence of pharma on research.